Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • 网际直通车
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • 网际直通车
    • Molecular Cancer Research
    • 网际直通车

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

老王加速度器官方

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • 网际直通车
    • Author Services
    • Best of: Author Profiles
    • First Disclosures
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • 网际直通车
    • Molecular Cancer Research
    • 网际直通车

老王加速度器官方

  • 网际直通车
  • Log in
  • My Cart

老王加速度器官方

  • Advanced search
网际直通车

老王加速度器官方

  • Home
  • About
    • The Journal
    • AACR Journals
    • 网际直通车
    • Permissions and Reprints
    • Reviewing
  • 网际直通车
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • Focus on Radiation Oncology
      • Novel Combinations
      • 网际直通车
      • Editors' Picks
      • 网际直通车
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • First Disclosures
    • Submit
  • 网际直通车
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • Search More

    Advanced Search

The AACR remains fully committed to supporting publishing operations throughout this challenging time, while still remaining flexible and supportive of the author, reviewer, and editor communities that we serve. If you have any questions or concerns, please reach out to a member of the AACR publishing staff.

 

Announcing our new Impact Factor: 5.615

  • 网际直通车
    July 2023
    Read the July issue!
  • First Disclosure
    First Disclosure: MMAE Delivery Using the Bicycle Toxin Conjugate BT5528
    Gavin Bennett, et al.
  • The Dysregulated Pharmacology of Clinically Relevant ESR1 Mutants is Normalized by Ligand-activated WT Receptor
    The Dysregulated Pharmacology of Clinically Relevant ESR1 Mutants is Normalized by Ligand-activated WT Receptor
    Kaitlyn J. Andreano, et al.
  • Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734
    Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734
    Chevaun D. Morrison-Smith, et al.
  • 1
  • 2
  • 3
  • 4

老王加速度器官方

  • 网际直通车
    Small Molecule Therapeutics | AuthorChoice
    MMAE Delivery Using the 网际直通车 Toxin Conjugate BT5528
    Gavin Bennett, Amy Brown, Gemma Mudd, Philip Huxley, Katerine Van Rietschoten, Silvia 网际直通车, 网际直通车 Chen, Sophie Watcham, Johanna Lahdenranta and 网际直通车 Keen
    Mol Cancer Ther July 1 2023 19 (7) 1385-1394; DOI:10.1158/1535-7163.MCT-19-1092

  • Large Molecule Therapeutics
    Inhibition of Tumor Cell Growth and Cancer Stem Cell Expansion by a Bispecific Antibody Targeting EGFR and HER3
    Alexander Rau, Wolfgang S. Lieb, Oliver Seifert, Jonas Honer, Dennis Birnstock, Fabian Richter, Nadine Aschmoneit, Monilola A. Olayioye and Roland E. Kontermann
    Mol Cancer Ther July 1 2023 19 (7) 1474-1485; 中国行业云安全PCSF论坛推动私有云等级保护升级-伋业 ...:2021-10-26 · 联系我伊 邮箱登录 通行证登录 网站地图

  • Companion Diagnostic, Pharmacogenomic, and Cancer Biomarkers | AuthorChoice
    高清盗版风暴:大年初三,我已经下载好全部春节档电影 ...:2021-4-29 · 8年前,知名盗版网站VeryCD一度传出关停消息,曾引起大量网友涌入网站,希望抢在关停前把资源都下载下来。8年后,《流浪地球》主创的微博下,网友的留言却变成了举报盗版链接。“每天都有观众给我伊发来的私信,协助我伊打击盗版。这是我最没想到的,非常感动。
    Andrew A. Davis, Wade T. Iams, David Chan, Michael S. Oh, Robert W. Lentz, Neil Peterman, Alex 网际直通车, Abhik Shah, Rohith Srivas, Timothy J. Wilson, Nicole J. Lambert, Peter S. 网际直通车, Becky Wong, Haleigh W. Wood, 网际直通车 Close, Ayse Tezcan, Ken Nesmith, Haluk Tezcan and Young Kwang Chae
    网际直通车 July 1 2023 19 (7) 1486-1496; DOI:10.1158/1535-7163.MCT-19-1060

  • Cancer Biology and Translational Studies
    Functional miRNA Screening Identifies Wide-ranging Antitumor Properties of miR-3622b-5p and Reveals a New Therapeutic Combination Strategy in Ovarian Tumor Organoids
    Mégane Vernon, Bernard Lambert, Matthieu Meryet-Figuière, Emilie Brotin, Louis-Bastien Weiswald, Hippolyte Paysant, Nicolas Vigneron, Anaïs Wambecke, Edwige 网际直通车, 网际直通车 Giffard, Marie-Hélène Louis, Cécile Blanc-Fournier, Pascal Gauduchon, Laurent 网际直通车 and Christophe Denoyelle
    Mol Cancer Ther July 1 2023 19 (7) 1506-1519; DOI:10.1158/1535-7163.MCT-19-0510

See the Table of Contents


老王加速度器官方

  • 网际直通车
    A Historic Perspective and Overview of H-Ras Structure, Oncogenicity, and Targeting
    Lihua Shu, Dongsheng Wang, Nabil F. Saba and Zhuo G. Chen
    Mol Cancer Ther April 1 2023 19 (4) 999-1007; DOI:10.1158/1535-7163.MCT-19-0660

  • Review
    The Ongoing Search for Biomarkers of CDK4/6 Inhibitor Responsiveness in Breast Cancer
    Scott F. Schoninger and Stacy W. Blain
    Mol Cancer Ther January 1 2023 19 (1) 3-12; DOI:10.1158/1535-7163.MCT-19-0253

  • Review | AuthorChoice
    Cabozantinib in Combination with Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence
    Paulo Bergerot, 网际直通车 Lamb, Evelyn Wang and Sumanta K. Pal
    Mol Cancer Ther December 1 2023 18 网际直通车2185-2193; DOI:10.1158/1535-7163.MCT-18-1399

  • Reviews | AuthorChoice
    ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications
    Samantha A. Armstrong, Christopher W. Schultz, Ariana Azimi-Sadjadi, Jonathan R. Brody and Michael J. Pishvaian
    Mol Cancer Ther November 1 2023 18 (11) 1899-1908; DOI:10.1158/1535-7163.MCT-19-0208

网际直通车

老王加速度器官方

  • mTOR blockade arrests tumors, increases let7, decreases CDK6
    Joy Gary, et al.
  • Predictive and prognostic biomarkers for regorafenib
    Yingmiao Liu, et al.
  • TMB and Overall Survival
    Paul Riviere, et al.
  • 周刊 - chinacourt.org:2021-10-24 · 群众反映问题,开通民意网上直通 车。黑龙江高院还制定了《“院长信 箱”所涉案件、事项办理工作的实施 细则》,规范信箱留言的梳理、批 转、办理和答复等流程。目前,全省 三级法院192个法院网站都开通了 “院长信箱”,极大地方便了当事人反 映诉求。
    网际直通车 Rago, et al.
Load more
Advertisement

Back to top
  • 网际直通车
  • 网际直通车
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

老王加速度器官方

  • Online First
  • 网际直通车
  • Past Issues
  • Meeting Abstracts

老王加速度器官方

  • Authors
  • Subscribers
  • 网际直通车
  • Librarians
  • Reviewers

老王加速度器官方

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2023 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

网际直通车